Cancer and malignant tumors
Conditions
Interventions
None listed
Sponsors
Shonan University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Cancer patients currently hospitalized who do not self-administer medical opioids. Patients who have provided informed consent and possess sufficient cognitive function to participate in a pain interview within 24 hours Patients whose resting pain is controlled and whose baseline opioid dosage has been stabilized Patients who have been prescribed rescue opioids to manage breakthrough pain Note Since breakthrough pain is defined as physiologically sudden pain that occurs despite resting pain being controlled by baseline opioid therapy, this study targets patients whose resting pain is controlled and whose baseline opioid dosage has been stabilized.
Exclusion criteria
Exclusion criteria: Patients who do not meet the inclusion criteria Patients under the age of 18 Patients unable to complete questionnaires or similar assessments (e.g., due to cognitive impairment) Patients unable to accurately describe their pain (e.g., unable to answer the NRS) Other, as determined by the principal investigator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The time from the onset of breakthrough pain until rescue opioids are administered | — |
Secondary
| Measure | Time frame |
|---|---|
| Pain intensity (NRS) at onset and at medication administration Time to pain relief Minimum pain intensity (NRS) Rate of achieving personal pain goals Satisfaction (with pain relief and time to rescue medication administration) Adherence to rescue opioid medication and reasons for non-adherence Time of day rescue medication was administered | — |
Countries
Japan
Contacts
Public ContactJunya Sato
Shonan University of Medical Sciences School of Pharmacy
Outcome results
None listed